Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Taiwan Biomateiral CoROCO:6649 -0.93%74 Days Payable is 64.57 as of Dec. 2025, which is 35% above its 10-year median of 47.87. GuruFocus rates ROCO:6649 with a GF Score™ of 74/100 and a GF Value™ of NT$77.96 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Taiwan Biomateiral Co ranks worse than 79.09% on this metric.
The historical rank and industry rank for Taiwan Biomateiral Co's Days Payable or its related term are showing as below:
ROCO:6649'
s Days Payable Range Over the Past 10 Years
Min: 2.86 Med: 47.87 Max: 89.09
Current: 35.93
During the past 13 years, Taiwan Biomateiral Co's highest Days Payable was 89.09. The lowest was 2.86. And the median was 47.87.
ROCO:6649's Days Payable is ranked worse than 79.09% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ROCO:6649: 35.93
Taiwan Biomateiral Co Days Payable Historical Data
* Premium members only.
The historical data trend for Taiwan Biomateiral Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6649 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Taiwan Biomateiral Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiwan Biomateiral Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Biomateiral Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Taiwan Biomateiral Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Taiwan Biomateiral Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiwan Biomateiral Co (ROCO:6649) has a Days Payable of 64.57 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Taiwan Biomateiral Co and its competitors. This is 35% above median its historical median of 47.87. Over the past decade, Taiwan Biomateiral Co's Days Payable has ranged from 2.86 to 89.09. According to the industry distribution chart, Taiwan Biomateiral Co ranks #628 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 79.1%.
Is Taiwan Biomateiral Co's Days Payable too high?
Taiwan Biomateiral Co's current Days Payable of 64.57 is 35% above median its 10-year median of 47.87. Over the past 10 years, this metric has ranged from a low of 2.86 to a high of 89.09. The Medical Devices & Instruments industry median Days Payable is 67.97. Taiwan Biomateiral Co's value of 64.57 is 5% below this industry median. Based on the distribution chart, Taiwan Biomateiral Co ranks #628 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Taiwan Biomateiral Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Taiwan Biomateiral Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Taiwan Biomateiral Co ranks #628 out of 794 companies for Days Payable. This places Taiwan Biomateiral Co in the lower half of its industry. The industry median Days Payable is 67.97. Taiwan Biomateiral Co's value of 64.57 is 5% below this benchmark. Historically, Taiwan Biomateiral Co's own Days Payable has ranged from 2.86 to 89.09 over the past decade. While the company's 10-year median is 47.87 vs. the industry median of 67.97, Taiwan Biomateiral Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiwan Biomateiral Co's current Days Payable of 64.57 is 5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Taiwan Biomateiral Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiwan Biomateiral Co's current Days Payable is 64.57, which is 35% above median its own 10-year median of 47.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Biomateiral Co stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Biomateiral Co (ROCO:6649) is currently considered Possible Value Trap. The stock's GF Value™ is NT$77.96, compared to a current price of NT$37.40 — trading 52% below its estimated fair value. The current Days Payable is 64.57, which is 35% above median its 10-year median of 47.87 and 5% below the Medical Devices & Instruments industry median of 67.97. Taiwan Biomateiral Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Taiwan Biomateiral Co (ROCO:6649), the current Days Payable is 64.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiwan Biomateiral Co (ROCO:6649) Overvalued in 2026?
Based on GuruFocus' analysis, Taiwan Biomateiral Co stock appears to be undervalued.
The current stock price of NT$37.40 is trading 52% below its estimated GF Value™ of NT$77.96.
GuruFocus considers Taiwan Biomateiral Co to be Possible Value Trap.
Key valuation signals for ROCO:6649:
Days Payable: 64.57 (35% above median its 10-year median of 47.87)
GF Value™: NT$77.96 vs. price of NT$37.40 (52% below fair value)
Industry Position: 5% below the Medical Devices & Instruments median (#628 of 794)
No single metric tells the full story. See the ROCO:6649 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiwan Biomateiral Co Ltd is an applied technology Research and Development Institute in Taiwan. It is engaged in the research and development and sales of implantable medical devices. The company's products include Foamagen, stroke interventional treatment devices.
74GF Score
Get the complete analysis for ROCO:6649
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6649 has been successfully added to your 
